INTC vs SYRE · rev $29.70B vs $7.60B cap
Intel Corporation (INTC) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Lip-Bu Tan.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported INTC revenue for 2026-06-27 was $29.70B. Net income was -$14.76B. INTC currently screens at market cap $498.43B.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
INTC currently screens at market cap $498.43B. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the INTC and SYRE stock pages for the full models.
Not investment advice.